Electrophysiological analysis of exogenous and endogenous adenosine actions in the rat and human hippocampus in vitro

Helmut L. Haas, Urs Gerber, Robert W. Greene, David R. Stevens

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Adenosine acts in at least three different ways at A1 receptors in order to reduce excitability and signal transfer. In the hippocampus, it causes in a steady state outward (potassium) current which is blocked by barium ions and not sensitive to voltage; (ii) an increase in the calcium and cyclic AMP‐dependent current 1AHP which is responsible for a long lasting afterhyperpolarization and the accommodation of action potential firing; (iii) a presynaptic reduction of excitatory but not inhibitory transmitter release. The mechanism of this effect is unclear. It is, in contrast to the former, not sensitive to pertussis toxin. When the adenosine elicited potassium currents at the postsynaptic site are blocked, slow inward currents, normally carried by calcium, are unaffected by adenosine. A2 receptor mediated actions have not been found in the hippocampus. While the precise analysis of these effects has been done largely on rats they were all found in human hippocampal slices as well. © 1993 Wiley‐Liss, Inc.

Original languageEnglish (US)
Pages (from-to)386-389
Number of pages4
JournalDrug Development Research
Volume28
Issue number3
DOIs
StatePublished - 1993

Fingerprint

Adenosine
Hippocampus
Potassium
Calcium
Synaptic Potentials
Pertussis Toxin
Barium
varespladib methyl
Action Potentials
Ions
In Vitro Techniques

Keywords

  • calcium
  • cyclic AMP
  • electrophysiology
  • potassium

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Electrophysiological analysis of exogenous and endogenous adenosine actions in the rat and human hippocampus in vitro. / Haas, Helmut L.; Gerber, Urs; Greene, Robert W.; Stevens, David R.

In: Drug Development Research, Vol. 28, No. 3, 1993, p. 386-389.

Research output: Contribution to journalArticle

@article{8e3d251963ac43faa23a2ec8f71875e7,
title = "Electrophysiological analysis of exogenous and endogenous adenosine actions in the rat and human hippocampus in vitro",
abstract = "Adenosine acts in at least three different ways at A1 receptors in order to reduce excitability and signal transfer. In the hippocampus, it causes in a steady state outward (potassium) current which is blocked by barium ions and not sensitive to voltage; (ii) an increase in the calcium and cyclic AMP‐dependent current 1AHP which is responsible for a long lasting afterhyperpolarization and the accommodation of action potential firing; (iii) a presynaptic reduction of excitatory but not inhibitory transmitter release. The mechanism of this effect is unclear. It is, in contrast to the former, not sensitive to pertussis toxin. When the adenosine elicited potassium currents at the postsynaptic site are blocked, slow inward currents, normally carried by calcium, are unaffected by adenosine. A2 receptor mediated actions have not been found in the hippocampus. While the precise analysis of these effects has been done largely on rats they were all found in human hippocampal slices as well. {\circledC} 1993 Wiley‐Liss, Inc.",
keywords = "calcium, cyclic AMP, electrophysiology, potassium",
author = "Haas, {Helmut L.} and Urs Gerber and Greene, {Robert W.} and Stevens, {David R.}",
year = "1993",
doi = "10.1002/ddr.430280336",
language = "English (US)",
volume = "28",
pages = "386--389",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Electrophysiological analysis of exogenous and endogenous adenosine actions in the rat and human hippocampus in vitro

AU - Haas, Helmut L.

AU - Gerber, Urs

AU - Greene, Robert W.

AU - Stevens, David R.

PY - 1993

Y1 - 1993

N2 - Adenosine acts in at least three different ways at A1 receptors in order to reduce excitability and signal transfer. In the hippocampus, it causes in a steady state outward (potassium) current which is blocked by barium ions and not sensitive to voltage; (ii) an increase in the calcium and cyclic AMP‐dependent current 1AHP which is responsible for a long lasting afterhyperpolarization and the accommodation of action potential firing; (iii) a presynaptic reduction of excitatory but not inhibitory transmitter release. The mechanism of this effect is unclear. It is, in contrast to the former, not sensitive to pertussis toxin. When the adenosine elicited potassium currents at the postsynaptic site are blocked, slow inward currents, normally carried by calcium, are unaffected by adenosine. A2 receptor mediated actions have not been found in the hippocampus. While the precise analysis of these effects has been done largely on rats they were all found in human hippocampal slices as well. © 1993 Wiley‐Liss, Inc.

AB - Adenosine acts in at least three different ways at A1 receptors in order to reduce excitability and signal transfer. In the hippocampus, it causes in a steady state outward (potassium) current which is blocked by barium ions and not sensitive to voltage; (ii) an increase in the calcium and cyclic AMP‐dependent current 1AHP which is responsible for a long lasting afterhyperpolarization and the accommodation of action potential firing; (iii) a presynaptic reduction of excitatory but not inhibitory transmitter release. The mechanism of this effect is unclear. It is, in contrast to the former, not sensitive to pertussis toxin. When the adenosine elicited potassium currents at the postsynaptic site are blocked, slow inward currents, normally carried by calcium, are unaffected by adenosine. A2 receptor mediated actions have not been found in the hippocampus. While the precise analysis of these effects has been done largely on rats they were all found in human hippocampal slices as well. © 1993 Wiley‐Liss, Inc.

KW - calcium

KW - cyclic AMP

KW - electrophysiology

KW - potassium

UR - http://www.scopus.com/inward/record.url?scp=0027520975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027520975&partnerID=8YFLogxK

U2 - 10.1002/ddr.430280336

DO - 10.1002/ddr.430280336

M3 - Article

VL - 28

SP - 386

EP - 389

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 3

ER -